FDA always do get a spoil frrom the MMs. They let it run just to short the snot out of em. I hope all were selling for a base of free shares. Its the way you have to play these. Now give me a 501K approval with a marketing partner coming in with a cash infusion and these fly. Orpan status is good for the time line, but its a snall population of patients, hence the getty up on the time. GENZ has built a power house on orphan status drugs. Ya got time to buy back in after it falls. Probably have a few more times to fliup for even more free shares to ride into that big FDA unknown approval letter.